Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (201-210 of 257) with videos related to

Pageof 26
Sort By:
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.
Nature Genetics|February 8, 2011
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
JAMA|January 30, 2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Wenjian Yang, et al.
The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology groupXuexia Wang, Wei Liu, Can-Lan Sun, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Pageof 26

Showing results (201-210 of 257) with videos related to

Sort By:
Pageof 26
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932Anne L Angiolillo, Reuven J Schore, John A Kairalla, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu, Cheng Cheng, Meenakshi Devidas, et al.
Nature Genetics|February 8, 2011
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
JAMA|January 30, 2009
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Wenjian Yang, et al.
The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology groupXuexia Wang, Wei Liu, Can-Lan Sun, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Pageof 26